Overview

AP-003-A A Efficacy and Safety Study of Two Doses of Intra-Articular Injection of Ampion™ in Adults With Pain Due to Osteoarthritis of the Knee

Status:
Completed

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy of two doses of Intra-Articular Injection of Ampion™ in Adults with pain due to osteoarthritis of the knee.

Phase:

Phase 3

Details

Lead Sponsor:

Ampio Pharmaceuticals. Inc.